Pei Hu Selected Research

Pei Hu Research Topics

Disease

21	Neoplasms (Cancer) 01/2021 - 07/2011
15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 07/2011
8	Infections 01/2020 - 11/2014
7	Rheumatoid Arthritis 11/2021 - 01/2016
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2021 - 11/2016
5	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2009
4	Osteoporosis 06/2021 - 05/2013
4	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 01/2018
4	Diarrhea 01/2018 - 08/2014
3	Hypoxia (Hypoxemia) 07/2022 - 01/2019
3	Sepsis (Septicemia) 01/2022 - 01/2017
3	Nausea 05/2021 - 08/2014
3	Diabetes Mellitus 01/2021 - 01/2017
3	Liver Diseases (Liver Disease) 09/2019 - 11/2014
3	Ischemic Stroke 08/2018 - 12/2008
3	Hepatitis B 03/2018 - 09/2015
3	Exanthema (Rash) 01/2018 - 07/2009
3	Ovarian Epithelial Carcinoma 03/2014 - 01/2013
2	Body Weight (Weight, Body) 01/2022 - 07/2020
2	Hemorrhage 01/2022 - 07/2017
2	Disease Progression 01/2022 - 07/2011
2	Inflammation (Inflammations) 10/2021 - 07/2019
2	Constipation 01/2021 - 01/2020
2	Parkinson Disease (Parkinson's Disease) 05/2020 - 02/2019
2	Hypertension (High Blood Pressure) 01/2020 - 01/2010
2	Measles 01/2018 - 06/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 05/2014
2	Headache (Headaches) 10/2016 - 07/2009
2	Chronic Obstructive Pulmonary Disease (COPD) 09/2016 - 06/2015
2	Dizziness (Lightheadedness) 02/2016 - 08/2014
2	Myalgia 02/2016 - 07/2009
2	Neoplasm Metastasis (Metastasis) 01/2014 - 03/2013
1	Chronic Renal Insufficiency 07/2022
1	Anemia 07/2022
1	Thrombosis (Thrombus) 01/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2021
1	Experimental Arthritis 08/2021
1	Vomiting 05/2021
1	Insulin Resistance 01/2021
1	Osteosarcoma (Osteogenic Sarcoma) 09/2020

Drug/Important Bio-Agent (IBA)

15	Pharmaceutical PreparationsIBA 07/2022 - 08/2011
10	Proteins (Proteins, Gene)FDA Link 04/2021 - 01/2016
8	Tyrosine Kinase InhibitorsIBA 01/2022 - 07/2009
7	icotinibIBA 09/2015 - 07/2011
6	abivertinibIBA 01/2022 - 11/2016
6	ErbB Receptors (EGF Receptor)IBA 12/2018 - 07/2011
3	kukoamine BIBA 01/2022 - 01/2017
3	imigliptinIBA 01/2021 - 08/2018
3	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2021 - 02/2017
3	GlypicansIBA 01/2019 - 01/2018
3	Liposomes (Liposome)IBA 01/2018 - 02/2013
3	VaccinesIBA 01/2018 - 06/2015
3	Vincristine (Oncovin)FDA LinkGeneric 01/2018 - 02/2013
3	PlatinumIBA 03/2014 - 01/2013
2	EnzymesIBA 07/2022 - 01/2021
2	Monoclonal AntibodiesIBA 11/2021 - 11/2016
2	LipopolysaccharidesIBA 10/2021 - 03/2017
2	Palonosetron (Aloxi)FDA Link 05/2021 - 01/2021
2	Small Interfering RNA (siRNA)IBA 09/2020 - 01/2019
2	CholesterolIBA 07/2020 - 02/2013
2	Polysaccharides (Glycans)IBA 07/2020 - 12/2018
2	Neuroprotective AgentsIBA 05/2020 - 12/2008
2	BilirubinIBA 01/2020 - 07/2009
2	Alanine Transaminase (SGPT)IBA 01/2020 - 01/2018
2	teriflunomideIBA 08/2019 - 07/2019
2	Leflunomide (Arava)FDA LinkGeneric 08/2019 - 07/2019
2	SodiumIBA 08/2019 - 07/2019
2	Biomarkers (Surrogate Marker)IBA 05/2019 - 09/2015
2	TabletsIBA 04/2019 - 11/2017
2	CurcuminIBA 01/2019 - 09/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 08/2015
2	CateninsIBA 01/2019 - 01/2018
2	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 08/2018 - 01/2009
2	Transaminases (Aminotransferases)IBA 01/2018 - 01/2018
2	Antiviral Agents (Antivirals)IBA 09/2017 - 11/2014
2	Gefitinib (Iressa)FDA Link 03/2016 - 03/2013
2	Cytochrome P-450 CYP2C19IBA 01/2014 - 12/2012
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 07/2022
1	roxadustatIBA 07/2022
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2022
1	AntibodiesIBA 11/2021
1	Enhancer of Zeste Homolog 2 ProteinIBA 10/2021
1	AdiponectinIBA 06/2021
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 05/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	alogliptinIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	netupitantIBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2021
1	polyethylene glycol-recombinant human growth hormoneIBA 01/2021
1	Insulin-Like Growth Factor Binding Protein 2IBA 01/2021
1	artenimol (dihydroartemisinin)IBA 11/2020
1	Cofilin 1IBA 09/2020

Therapy/Procedure

5	Oral Administration 08/2021 - 09/2016
5	Drug Therapy (Chemotherapy) 05/2021 - 07/2011
3	Therapeutics 01/2021 - 07/2009
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 08/2021 - 10/2016
2	Glycemic Control 07/2015 - 01/2009
1	Transplantation 09/2020